Β LACTA test performance for detection of extended-spectrum β-lactamase-producing Gram-negative bacilli directly on bronchial aspirates samples: a validation study. (April 2018)

• Record Type: Journal Article
• Authors: Gallah, S.; Benzerara, Y.; Tankovic, J.; Woerther, P.-L.; Bensekri, H.; Mainardi, J.-L.; Arlet, G.; Vimont, S.; Garnier, M.
• Is Part Of: Clinical microbiology and infection. Volume 24:Number 4(2018)
• Page Start: 402
• Page End: 408
• Publication Date: 2018-04
• Subjects: β-lactam resistance -- Antimicrobial agent administration -- Bacterial pneumonia -- Early diagnosis -- Extended-spectrum β-lactamase -- Microbial susceptibility tests; Medical microbiology -- Periodicals; Diagnostic microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.01
• DOI: 10.1016/j.cmi.2017.07.030
• Languages: English
• ISSNs: 1198-743X

Abstract

Abstract: Objectives: Incidence of extended-spectrum β-lactamase-producing Gram-negative bacilli (ESBL-PE-GNB)-related infections is worryingly increasing worldwide. ESBL-PE-GNB detection directly on bronchial aspirate samples (BAS) performed for suspected pneumonia may help save empirical carbapenems. Our objectives were to optimize β-LACTA™ test (BLT) realization and evaluate BLT performance for ESBL-PE-GNB detection directly on BAS. Methods: We studied BLT technical optimization using BAS of different matrix types spiked with increasing concentrations of CTX-M-15-producing Klebsiella pneumoniae; in vitro validation of BLT diagnostic performance on 17 ESBL enzymes, belonging to CTX-M, SHV, TEM, OXA, GES, VEB and PER groups; and clinical validation of BLT performance on 126 BAS prospectively collected from seven intensive care units. Results: After optimization, BLT detected with 100% sensitivity the presence of CTX-M-15-producing K. pneumoniae spiked in sterile BAS for inoculums upon two or more GNB per field upon microscopic Gram staining examination (MGSE). The BLT accurately detected the 17 ESBLs tested at 10 6 CFU/mL and all ESBLs except Pseudomonas aeruginosa –related OXA-14 at 10 4 CFU/mL. Among the 126 BAS of the validation cohort, 21 (17%) gave positive BLT (ten in BAS positive and 11 in BAS negative on MGSE). All BLT-positive BAS grew with ESBL-PE-GNB, including five hyper-L2-producing Stenotrophomonas maltophilia strains. BLT detected ESBL-PE-GNB directly on clinical BAS positive for GNB on MGSE and/or growing with ≥10 4 CFU/mL with 100% sensitivity, specificity, and positive and negative predictive values. Conclusions: BLT is an accurate tool for ESBL-PE-GNB detection directly on BAS. Further studies are needed to evaluate the impact of BLT-guided early antimicrobial de-escalation strategies.